ABP 980
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABP 980, covering 2019-08-07 to 2019-08-07. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer [Phase 3]